Treatment of Depression in Patients with Epilepsy
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
In this article, we review the current best evidence for the treatment of depression in patients with epilepsy. Depression is a common epilepsy comorbidity, but it is often unrecognized. The most important step in appropriately managing mood disorders in this population is making the diagnosis. Clinical vigilance and routine use of a validated screening tool can improve detection and quality of care. As is increasingly the case for the general population, persons with epilepsy are often interested in exploring alternative therapies for chronic conditions, including depression. Unfortunately, the benefit of complementary and alternative therapies for depression currently is largely unproven for persons with a seizure history, although an early study of exercise for mild depression has shown some benefit. Concerns about drug interactions, side effects, and expense may be barriers to the prescription of antidepressant medications for people requiring chronic antiepileptic drug (AED) therapy. For this reason, use of an AED with mood-stabilizing properties has appeal and may be appropriate for selected individuals with mild depressive symptoms. Undue fear of lowering seizure threshold should not preclude the prescription of an antidepressant medication, as the perceived risks are often overestimated and rarely outweigh the risk of leaving depression untreated. At present, the best evidence for efficacy and safety support the use of citalopram, sertraline, or mirtazapine as initial pharmacotherapy, whereas bupropion should be avoided. Start low, go slow, and use the lowest effective dose. Cognitive behavioral therapy is a valuable adjunct to antidepressant therapy in this population. For people with refractory partial epilepsy and refractory depression, vagus nerve stimulation has some appeal, in that it may be beneficial for both conditions, but the efficacy of vagus nerve stimulation in improving mood in patients with epilepsy remains unclear.
- Tellez-Zenteno JF, Patten SB, Jette N, Williams J, Wiebe S. Psychiatric comorbidity in epilepsy: a population based analysis. Epilepsia. 2007;48:2336–44.
- Karouni M, Arulthas S, Larsson PG, et al. Psychiatric comorbidity in patients with epilepsy: a population based study. Eur J Clin Pharmacol. 2010;66:1151–60. CrossRef
- Gaitatzis A, Carrol K, Majeed A, Sander W. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia. 2004;45:1613–22. CrossRef
- Barry JJ, Ettinger AB, Friel P, et al. Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav. 2008;13:S1–29. CrossRef
- Gilliam FC, Barry JJ, Hermann BP, et al. Rapid detection of major depression in epilepsy: a multicenter study. Lancet Neurol. 2006;5:399–405. CrossRef
- Pilling S, Anderson I, Goldberg D, et al. Depression in adults, including those with a chronic physical health problem: summary of NICE guidance. BMJ. 2009;339:1025–7. CrossRef
- McAuley JW, Long L, Heise J, Kirby T, et al. A prospective evaluation of the effects of a 12 week outpatient exercise program on clinical and behavioral outcomes in patients with epilepsy. Epilepsy Behav. 2001;2:592–600. CrossRef
- Sirven JI, Drazkowski JF, Zimmerman RS, et al. Complementary/alternative medicine for epilepsy in Arizona. Neurology. 2003;61:576–7.
- Linde K, Berner MM, Kriston L. St John’s wort for major depression. Cochrane Database Syst Rev 2008;(4):CD000448.
- Borrelli F, Izzo AA. Herb-drug interactions with St. John’s wort (Hypericum perforatum): an update on clinical observations. AAPS J. 2009;11:710–27. CrossRef
- Edeh J, Toone BK. Antiepileptic therapy, folate deficiency, and psychiatric comorbidity: a general practice survey. Epilepsia. 1995;26:434–40. CrossRef
- Rosche J, Uhlmann C, Froscher W. Low serum folate levels as a risk factor for depressive mood in patients with chronic epilepsy. J Neuropsychiatry Clin Neurosci. 2003;15:64–6. CrossRef
- Froscher W, Maier V, Laage M, et al. Folate deficiency, anticonvulsant drugs, and psychiatric comorbidity. Clin Neuropharmacol. 1995;18:165–82. CrossRef
- Miller JM, Kustra RP, Vuong A, Hammer AE, Messenheimer JA. Depressive symptoms in epilepsy: prevalence, impact, aetiology, biological correlates and effect of treatment with antiepileptic drugs. Drugs. 2008;68:1493–509. CrossRef
- U.S. Department of Health and Human Services. Statistical review and evaluation: antiepileptic drugs and suicidality. Available at http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4372b1-01-FDA.pdf. Accessed March 23, 2011.
- Patorno E, Bohn RL, Wahl PM, et al. Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA. 2010;303:1401–9. CrossRef
- Arana A, Wentworth CE, Ayuso-Mateos JL, Arellano FM. Suicide-related events in patients treated with antiepileptic drugs. N Engl J Med. 2010;363:542–51. CrossRef
- Andersohn F, Schade R, Willich SN, Garbe E. Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior. Neurology. 2010;75:335–40. CrossRef
- Kühn KU, Quednow BB, Thiel M, et al. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy Behav. 2003;4:674–9. CrossRef
- Kanner AM, Kozak AM, Frey M. The use of sertraline in patients with epilepsy: is it safe? Epilepsy Behav. 2000;1:100–5. CrossRef
- Havorka J, Herman E, Nemcova I. Treatment of interictal depression with citalopram in patients with epilepsy. Epilepsy Behav. 2000;1:444–7. CrossRef
- Specchio LM, Iudice A, Specchio N, et al. Citalopram as treatment of depression in patients with epilepsy. Clin Neuropharmacol. 2004;27:133–6. CrossRef
- Cotterman-Hart S. Depression in epilepsy: Why aren’t we treating? Epilepsy Behav. 2010;19:419–21. CrossRef
- Alper K, Schwartz KA, Kolts RL, Khan A. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry. 2007;62:345–54. CrossRef
- Johnston JA, Lineberry CG, Ascher JA, et al. A 102-center prospective study of seizure in association with bupropion. J Clin Psychiatry. 1991;52:450–6.
- Gross A, Devinsky O, Westbrook LE, Wharton AH, Alper K. Psychotropic medication use in patients with epilepsy: effect on seizure frequency. J Neuropsychiatry Clin Neurosci. 2000;12:458–64. CrossRef
- Spina E, Santoro V, D’Arrigo C. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. Clin Ther. 2008;30:1206–27. CrossRef
- George MS, Rush AJ, Marangell LB, et al. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment resistant depression. Biol Psychiatry. 2005;58:364–73. CrossRef
- Rush JA, Marangell LB, Sackeim HA, et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry. 2005;58:347–54. CrossRef
- Harden CL, Pulver MC, Ravdin LD, et al. A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav. 2000;1:93–9. CrossRef
- Deckersbach T, Gershuny BS, Otto MW. Cognitive behavioral therapy for depression. Applications and outcome. Psychiatr Clin North Am. 2000;23:795–809. CrossRef
- Dobson KS. A meta-analysis of the efficacy of cognitive therapy for depression. J Consult Clin Psychol. 1989;57:414–9. CrossRef
- Robinson LA, Berman JS, Neimeyer RA. Psychotherapy for the treatment of depression: a comprehensive review of controlled outcome research. Psychol Bull. 1990;108:30–49. CrossRef
- McLean PD, Hakstian AR. Relative endurance of unipolar depression treatment effects: longitudinal follow-up. J Consult Clin Psychol. 1990;58:482–8. CrossRef
- Ramaratnam S, Baker GA, Goldstein LH. Psychological treatments for epilepsy. Cochrane Database Syst Rev 2008;Issue 1:CD002029. DOI: 10.1002/14651858.CD002029.pub3.
- Ciechanowski P, Chaytor N, Miller J, et al. PEARLS depression treatment for individuals with epilepsy: a randomized controlled trial. Epilepsy Behav. 2010;19:225–31. CrossRef
- Goldstein LH, McAlpine M, Deale A, et al. Cognitive behavior therapy with adults with intractable epilepsy and psychiatric co-morbidity: preliminary observations on changes in psychological state and seizure frequency. Behav Res Ther. 2003;41:447–60. CrossRef
- Thompson NJ, Walker ER, Obolensky N, et al. Distance delivery of mindfulness based cognitive therapy for depression: Project UPLIFT. Epilepsy Behav. 2010;19:247–54. CrossRef
- Macrodimitris S, Weshler J, Hatfield M, et al. Group cognitive behavioral therapy for patients with epilepsy and comorbid anxiety and depression. Epilepsy Behav. 2011;20:83–8. CrossRef
- Kucia KA, Stepanczak R, Tredzbor B. Electroconvulsive therapy for major depression in an elderly person with epilepsy. World J Biol Psychiatry. 2009;10:78–80. CrossRef
- Lunde ME, Lee EK, Rasmussen KG. Electroconvulsive therapy in patients with epilepsy. Epilepsy Behav. 2006;9:355–9. CrossRef
- O’Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62:1208–16. CrossRef
- Treatment of Depression in Patients with Epilepsy
Current Treatment Options in Neurology
Volume 13, Issue 4 , pp 371-379
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Neurology, Mayo Clinic in Arizona, 5777 East Mayo Boulevard, Phoenix, AZ, 85054, USA
- 2. Department of Psychiatry and Psychology, Mayo Clinic in Arizona, 5777 East Mayo Boulevard, Phoenix, AZ, 85054, USA